Advancing Blood Pressure Monitoring During Outpatient Surgery
For patients and caregivers preparing for outpatient surgery, understanding how blood pressure is monitored can bring peace of mind. This clinical trial focuses on improving continuous blood pressure monitoring during elective noncardiac procedures using advanced finger cuff technology. The study will compare two approaches: one where the monitoring data is hidden from healthcare providers (blinded) and another where they have full access to real-time blood pressure information (unblinded).
Who Can Participate? The study is looking for adults aged 18 and older who are scheduled for elective outpatient surgery and have an ASA Physical Status of 2 or higher, indicating they have mild to severe systemic disease. Participants must not be pregnant, have significant differences in blood pressure between arms, or conditions that might interfere with proper device placement, such as Raynaud's disease or hand deformities.
What Does the Study Involve? Participants will be fitted with a HemoSphere Vita Monitor using specialized finger cuffs that continuously track blood pressure throughout their surgery. This non-invasive method aims to provide more consistent data compared to traditional arm cuffs, which only take intermittent readings. The primary goal is to measure how many patients experience hypotension (low blood pressure), specifically when the mean arterial pressure drops below 65 mmHg for at least five minutes. Detecting these episodes early is crucial because prolonged hypotension can lead to complications like organ damage or delayed recovery.
Why This Research Matters Blood pressure fluctuations during surgery are common but can pose serious risks if not managed promptly. Traditional monitoring methods might miss subtle changes, whereas continuous monitoring could allow healthcare teams to respond more quickly. This trial seeks to validate whether real-time data access improves patient outcomes by reducing the duration and severity of low blood pressure events. For patients, this could mean safer surgeries and smoother recoveries, while caregivers can feel reassured that their loved ones are being monitored with cutting-edge technology.
Clinical trials like this one are essential for advancing medical care. They help refine technologies that benefit future patients by ensuring devices are both effective and user-friendly. Research in surgical monitoring not only enhances safety protocols but also empowers healthcare providers with better tools to make informed decisions. As medical science evolves, continuous innovation in monitoring techniques promises to reduce complications, shorten hospital stays, and improve overall patient experiences. Participating in such studies contributes valuable data that can transform standard practices and elevate the quality of care for everyone undergoing surgical procedures.
If you or a loved one are considering involvement, it's important to discuss the study with your healthcare team to understand how it aligns with your health needs. Remember, informed consent is a key part of the process, ensuring you are fully aware of what participation entails. Research participation is voluntary, and your comfort and safety are always the top priority. By supporting studies like this, patients and caregivers play a vital role in driving medical progress that benefits communities worldwide.
Upcoming Clinical Trials
-
NCT07926477Not yet recruiting
-
NCT07904234Not yet recruitingOxygen Deficiency | Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) | Graft Function
-
NCT07926867Not yet recruiting
-
NCT07925281RecruitingAlcohol Use Disorder | Major Depressive Disorder (MDD)
-
NCT07925814Recruiting
-
NCT07927101Not yet recruitingLiver Regeneration | Postoperative Liver Injury
-
NCT07926074Not yet recruitingType 2 Diabetes Mellitus
-
NCT07927062Not yet recruitingDental Trauma; Traumatic Dental Injury; Parent Education / Emergency Decision-Making
-
NCT07925918Not yet recruiting
-
NCT07926906Not yet recruitingHead and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Hypopharyngeal Squamous Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
-
NCT07926698Not yet recruitingHematologic Malignancies | Acute Graft-Versus-Host Disease | Haploidentical Peripheral Blood Stem Cell Transplantation